CDON
Cell adhesion molecule-related/down-regulated by oncogenes
Also known as: CDO, CDON_HUMAN, CDON1, Ihog, ORCAM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q4KMG0
- Gene
- CDON
- Ensembl
- ENSG00000064309
- Chromosome
- 11
- Canonical length
- 1287 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a cell surface receptor that is a member of the immunoglobulin superfamily. The encoded protein contains three fibronectin type III domains and five immunoglobulin-like C2-type domains. This protein is a member of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells and positively regulates myogenesis. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
1287 residues, UniProt reviewed canonical sequence.
>Q4KMG0|CDON
1 MHPDLGPLCT LLYVTLTILC SSVSSDLAPY FTSEPLSAVQ KLGGPVVLHC SAQPVTTRIS
61 WLHNGKTLDG NLEHVKIHQG TLTILSLNSS LLGYYQCLAN NSIGAIVSGP ATVSVAVLGD
121 FGSSTKHVIT AEEKSAGFIG CRVPESNPKA EVRYKIRGKW LEHSTENYLI LPSGNLQILN
181 VSLEDKGSYK CAAYNPVTHQ LKVEPIGRKL LVSRPSSDDV HILHPTHSQA LAVLSRSPVT
241 LECVVSGVPA PQVYWLKDGQ DIAPGSNWRR LYSHLATDSV DPADSGNYSC MAGNKSGDVK
301 YVTYMVNVLE HASISKGLQD QIVSLGATVH FTCDVHGNPA PNCTWFHNAQ PIHPSARHLT
361 AGNGLKISGV TVEDVGMYQC VADNGIGFMH STGRLEIEND GGFKPVIITA PVSAKVADGD
421 FVTLSCNASG LPVPVIRWYD SHGLITSHPS QVLRSKSRKS QLSRPEGLNL EPVYFVLSQA
481 GASSLHIQAV TQEHAGKYIC EAANEHGTTQ AEASLMVVPF ETNTKAETVT LPDAAQNDDR
541 SKRDGSETGL LSSFPVKVHP SAVESAPEKN ASGISVPDAP IILSPPQTHT PDTYNLVWRA
601 GKDGGLPINA YFVKYRKLDD GVGMLGSWHT VRVPGSENEL HLAELEPSSL YEVLMVARSA
661 AGEGQPAMLT FRTSKEKTAS SKNTQASSPP VGIPKYPVVS EAANNNFGVV LTDSSRHSGV
721 PEAPDRPTIS TASETSVYVT WIPRANGGSP ITAFKVEYKR MRTSNWLVAA EDIPPSKLSV
781 EVRSLEPGST YKFRVIAINH YGESFRSSAS RPYQVVGFPN RFSSRPITGP HIAYTEAVSD
841 TQIMLKWTYI PSSNNNTPIQ GFYIYYRPTD SDNDSDYKRD VVEGSKQWHM IGHLQPETSY
901 DIKMQCFNEG GESEFSNVMI CETKVKRVPG ASEYPVKDLS TPPNSLGSGG NVGPATSPAR
961 SSDMLYLIVG CVLGVMVLIL MVFIAMCLWK NRQQNTIQKY DPPGYLYQGS DMNGQMVDYT
1021 TLSGASQING NVHGGFLTNG GLSSGYSHLH HKVPNAVNGI VNGSLNGGLY SGHSNSLTRT
1081 HVDFEHPHHL VNGGGMYTAV PQIDPLECVN CRNCRNNNRC FTKTNSTFSS SPPPVVPVVA
1141 PYPQDGLEMK PLSHVKVPVC LTSAVPDCGQ LPEESVKDNV EPVPTQRTCC QDIVNDVSSD
1201 GSEDPAEFSR GQEGMINLRI PDHLQLAKSC VWEGDSCAHS ETEINIVSWN ALILPPVPEG
1261 CAEKTMWSPP GIPLDSPTEV LQQPRETLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CDON can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- ovary: 14 nTPM
- smooth muscle: 12 nTPM
- thyroid gland: 12 nTPM
- skin: 9.2 nTPM
- retina: 6.1 nTPM
- endometrium: 5.6 nTPM
Single-cell type
- mesothelial cells: 537 nCPM
- fibro-adipogenic progenitors: 259 nCPM
- müller glia: 192 nCPM
- thyrotrophs: 145 nCPM
- lactotrophs: 138 nCPM
- epicardial cells: 130 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 23 nTPM
- pons: 3.8 nTPM
- cerebral cortex: 3.5 nTPM
- basal ganglia: 3.4 nTPM
- choroid plexus: 3.3 nTPM
- white matter: 3.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CDON.
Disease | AllUniProt
Conditions CDON is implicated in, by any mechanism.
- Holoprosencephaly 11 (HPE11) MIM:614226
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 812 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Holoprosencephaly 11
- Congenital ocular coloboma
- Pituitary stalk interruption syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.21
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterior/posterior pattern specification
- cell adhesion
- cell fate specification
- cell-cell adhesion
- cellular response to vitamin D
- central nervous system neuron differentiation
- cerebral cortex development
- embryonic body morphogenesis
- embryonic retina morphogenesis in camera-type eye
- lens development in camera-type eye
- myoblast fusion
- negative regulation of biomineral tissue development
- negative regulation of canonical Wnt signaling pathway
- nervous system development
- neuroblast proliferation
- positive regulation of MAPK cascade
- positive regulation of neuroblast proliferation
- positive regulation of neuron differentiation
- positive regulation of skeletal muscle tissue development
- positive regulation of small GTPase mediated signal transduction
- positive regulation of transcription by RNA polymerase II
- skeletal muscle satellite cell differentiation
- smoothened signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CDON in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CDON as an antibody target. Whether an autoantibody or antibody against CDON could matter depends on whether native CDON is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CDON is annotated at the cell surface, where native CDON is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CDON as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...